New relief from your allergies?
- Article by: ERIC BOODMAN , Pittsburgh Post-Gazette
- Updated: August 9, 2014 - 2:00 PM
Asha Patel knows more about what goes into your lungs than you do.
Every weekday at 8 a.m., the researcher climbs onto the roof of Allegheny General Hospital in Pittsburgh to check a Burkard Spore Trap. It looks like a cross between a praying mantis and a weather vane. As it rotates in the wind, it sucks air onto a strip of tape that Patel has painted with petroleum jelly. The particles floating through the air may be invisible to the rest of us, but when they get caught on that sticky surface, Patel looks at them under a microscope and knows exactly what they are.
She is in charge of Pittsburgh’s daily pollen and spore count, which she e-mails to allergists, their patients and weather channels. As many as 50 million Americans suffer from environmental allergies, according to the American College of Asthma, Allergies and Immunology, and pollen and spores are among the main culprits.
Avoiding these particles is impossible, so we spray steroids up our noses, take pills, squirt eye drops and go to the doctor for allergy shots. Now, we may be able to reshape our immune systems with allergy tablets that dissolve under the tongue, with brand names Ragwitek, Grastek and Oralair. These drugs were approved by the FDA this year, and while they could change allergy treatment in America, some doctors are skeptical.
Allergists explain that each kind of pollen or spore that Patel identifies fits perfectly into antibodies on a patient’s mast cells, a kind of white blood cell. “It’s like a hand in a glove,” says Dr. Andrej Petrov, an allergist at UPMC.
Deborah Gentile, an allergist at AGH, added that these Y-shaped antibodies are called immunoglobulin-E, and that they exist to help us fight off parasites. In the developing world, bodies contain armies of IgE, all waging a war on tropical bugs.
In industrialized countries like the United States, the relatively low concentrations of parasites should mean that our bodies have only tiny amounts of IgE. But in allergic bodies, the immune system mistakes something harmless for a parasite. When a particular species of pollen binds to that specific IgE, it creates a positive feedback loop: More IgE of that type is produced, which means that more pollen binds to it, and more histamine is released, creating an allergic reaction.
For people with mild allergies, treating the symptoms is often sufficient. By blocking receptors in the nose and throat, antihistamines prevent this chemical from inducing the reactions we associate with hay fever.
Itchy ears, runny nose
But for patients like Beth Koenig, 43, antihistamines are not enough. When she moved to Pittsburgh three years ago, she discovered she was particularly allergic to the Steel City’s allergens. Her lifelong symptoms became unbearable — sore throat, itchy ears, runny nose, and trouble breathing. “Your eyes itch and burn so much that if you could just take them out and wash them, it would feel like the best thing you’ve ever experienced,” she said.
Beyond avoidance (which was impossible) and symptom-based treatments (which did not work), there was one other option: immunotherapy. This class of treatment involves exposing the immune system to the allergen in increasing doses so your body stops viewing it as a parasite. By slowly upping the amount of the allergen in your body, immunotherapy stimulates the production of IgG, whose normal job is to fight off bacterial or viral infections without producing an inflammatory response.
Like a new rival gang staking out its territory, IgG competes with IgE, grabbing more of the allergens and preventing IgE from binding to mast cells and stimulating chemicals like histamine. “My holy grail is to change the immune system,” said Petrov, who prescribed these regular injections for Koenig.
His colleague, allergist Merritt Fajt, added that some people call these shots allergy vaccines because they can make environmental allergies disappear entirely.
Could pills replace shots?
Until now, injections were the only immunotherapy approved by the FDA. Most often, shots are scheduled weekly for five to six months and then monthly for three to five years.
The new drugs Grastek, Ragwitek and Oralair are taken at home. Once a day, for 12 weeks before and then throughout allergy season, patients slip a tablet under their tongue and wait for it to dissolve. No injections and only one appointment with the doctor. They, along with injections, have a small risk of producing allergic shock.
But Grastek and Oralair combat only grass allergies, and Ragwitek helps only with ragweed. Allergy shots are a personalized cocktail of allergens prepared for each patient by a nurse or researcher, like Patel.
And most people with serious allergies are sensitive to many, from tree and grass pollen to cockroaches and dust mites.
“In Europe, they treat the principal allergy, and they see improvement overall,” Gentile said. But she is worried about compliance, given that patients need to take these tablets every day for six months. “They have more than a 50 percent drop-off rate,” Petrov said.
While Gentile thinks that these new drugs will encourage more people to seek allergy care, most of Fajt’s patients at UPMC are not really eligible.
“It’s rare that I find a solo allergy,” she said. “I don’t even know if it would be safe to put multiple agents under the tongue.”